SUPN logo

Supernus Pharmaceuticals (SUPN) Current assets

annual current assets:

$686.07M+$192.96M(+39.13%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual total current assets is $686.07 million, with the most recent change of +$192.96 million (+39.13%) on December 31, 2024.
  • During the last 3 years, SUPN annual current assets has risen by +$84.48 million (+14.04%).
  • SUPN annual current assets is now -6.55% below its all-time high of $734.15 million, reached on December 31, 2022.

Performance

SUPN Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly current assets:

$687.58M+$1.51M(+0.22%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly total current assets is $687.58 million, with the most recent change of +$1.51 million (+0.22%) on March 31, 2025.
  • Over the past year, SUPN quarterly current assets has increased by +$143.26 million (+26.32%).
  • SUPN quarterly current assets is now -22.16% below its all-time high of $883.34 million, reached on March 31, 2023.

Performance

SUPN quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

SUPN Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+39.1%+26.3%
3 y3 years+14.0%+20.9%
5 y5 years+45.2%+23.4%

SUPN Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.5%+39.1%-22.2%+62.3%
5 y5-year-6.5%+45.2%-22.2%+62.3%
alltimeall time-6.5%+1623.2%-22.2%+2660.3%

SUPN Current assets History

DateAnnualQuarterly
Mar 2025
-
$687.58M(+0.2%)
Dec 2024
$682.00M(-13.1%)
$686.07M(+7.2%)
Sep 2024
-
$640.00M(+8.3%)
Jun 2024
-
$591.00M(+8.6%)
Mar 2024
-
$544.32M(+10.4%)
Dec 2023
$784.56M(-19.0%)
$493.11M(+9.7%)
Sep 2023
-
$449.36M(+6.1%)
Jun 2023
-
$423.54M(-52.1%)
Mar 2023
-
$883.34M(+20.3%)
Dec 2022
$968.36M(-11.0%)
$734.15M(+10.6%)
Sep 2022
-
$663.89M(+6.2%)
Jun 2022
-
$625.12M(+10.0%)
Mar 2022
-
$568.52M(-5.5%)
Dec 2021
$1.09B(+24.5%)
$601.59M(-10.0%)
Sep 2021
-
$668.38M(+4.6%)
Jun 2021
-
$639.24M(+9.1%)
Mar 2021
-
$586.02M(-7.0%)
Dec 2020
$873.68M(+27.1%)
$630.42M(+14.2%)
Sep 2020
-
$552.01M(-0.9%)
Jun 2020
-
$557.15M(+0.0%)
Mar 2020
-
$557.05M(+17.9%)
Dec 2019
$687.64M(+42.0%)
$472.64M(+10.7%)
Sep 2019
-
$427.08M(+9.3%)
Jun 2019
-
$390.91M(-6.9%)
Mar 2019
-
$419.97M(-14.9%)
Dec 2018
$484.32M(+147.1%)
$493.49M(+26.4%)
Sep 2018
-
$390.56M(+37.3%)
Jun 2018
-
$284.52M(-51.2%)
Mar 2018
-
$583.25M(+155.3%)
DateAnnualQuarterly
Dec 2017
$196.01M(+23.9%)
$228.45M(+19.4%)
Sep 2017
-
$191.33M(+15.6%)
Jun 2017
-
$165.49M(+10.5%)
Mar 2017
-
$149.76M(-1.1%)
Dec 2016
$158.16M(+91.3%)
$151.40M(+9.6%)
Sep 2016
-
$138.20M(+21.1%)
Jun 2016
-
$114.14M(+21.5%)
Mar 2016
-
$93.95M(-11.3%)
Dec 2015
$82.68M(+194.7%)
$105.95M(+3.3%)
Sep 2015
-
$102.55M(-3.0%)
Jun 2015
-
$105.74M(+4.2%)
Mar 2015
-
$101.50M(-6.6%)
Dec 2014
$28.06M(+102.8%)
$108.73M(+5.6%)
Sep 2014
-
$102.97M(+43.0%)
Jun 2014
-
$71.98M(-9.9%)
Mar 2014
-
$79.93M(-17.7%)
Dec 2013
$13.83M(+447.4%)
$97.16M(-5.5%)
Sep 2013
-
$102.86M(-7.0%)
Jun 2013
-
$110.62M(+44.9%)
Mar 2013
-
$76.33M(-16.5%)
Dec 2012
$2.53M(-41.7%)
$91.46M(+45.4%)
Sep 2012
-
$62.89M(-19.2%)
Jun 2012
-
$77.81M(+102.5%)
Mar 2012
-
$38.42M(-22.2%)
Dec 2011
$4.33M(-39.8%)
$49.40M(+98.3%)
Sep 2011
-
$24.91M(-37.4%)
Dec 2010
$7.20M(+2.5%)
$39.81M(-22.3%)
Sep 2010
-
$51.24M(-29.7%)
Dec 2009
$7.02M(-8.6%)
$72.88M
Dec 2008
$7.68M
-

FAQ

  • What is Supernus Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual current assets year-on-year change?
  • What is Supernus Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly current assets year-on-year change?

What is Supernus Pharmaceuticals annual total current assets?

The current annual current assets of SUPN is $686.07M

What is the all time high annual current assets for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual total current assets is $734.15M

What is Supernus Pharmaceuticals annual current assets year-on-year change?

Over the past year, SUPN annual total current assets has changed by +$192.96M (+39.13%)

What is Supernus Pharmaceuticals quarterly total current assets?

The current quarterly current assets of SUPN is $687.58M

What is the all time high quarterly current assets for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly total current assets is $883.34M

What is Supernus Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, SUPN quarterly total current assets has changed by +$143.26M (+26.32%)
On this page